Journal of Lipid Research, Vol. 23, 702-714, July 1982
Copyright © 1982 by Lipid Research, Inc.

Structural and metabolic heterogeneity of ßbeta;-very low density lipoproteins from cholesterol-fed dogs and from humans with Type III hyperlipoproteinemia

Menahem Fainaru , Robert W. Mahley , Robert L. Hamilton , and Thomas L. Innerarity

Gladstone Foundation Laboratories for Cardiovascular Disease, Cardiovascular Research Institute and Departments of Anatomy and Pathology, University of California, San Francisco, San Francisco, CA

Cholesteryl ester-rich ßbeta;-very low density lipoproteins (ßbeta;-VLDL) are ßbeta;-migrating lipoproteins that accumulate in the d < 1.006 g/ml fraction of plasma from cholesterol-fed animals and from patients with Type III hyperlipoproteinemia. They can be separated from pre-ßbeta;-migrating very low density lipoproteins in the d 1.006 g/ml fraction by Geon-Pevikon block electrophoresis. The ßbeta;-VLDL have a general property of stimulating cholesteryl ester synthesis and accumulation in macrophages. In the present study, we demonstrated that ßbeta;-VLDL obtained from cholesterol-fed dogs fasted for 16 hr were heterogeneous and that two subpopulations of particles, referred to as Fractions I and II, could be isolated from the whole ßbeta;-VLDL fraction using gel filtration chromatography. These fractions of ßbeta;-VLDL were similar in that both were cholesteryl ester rich, had ßbeta;-electrophoretic mobility on Geon-Pevikon electrophoresis, and possessed the B and E apoproteins as major constituents. However, Fractions I and II differed in size, shape, electrophoretic mobility, chemical composition, and apoprotein B type. (Fraction I vs. Fraction II: size: 90 to 300 nm vs. 20 to 70 nm; shape: irregular with redundant surface vs. spherical; electrophoretic mobility on paper: origin vs. ßbeta;; chemical composition: rich in phospholipid and poor in protein vs. rich in protein and poor in triglycerides; apoprotein B types: equal amounts of the high and low molecular weight forms vs. predominantly the high molecular weight form.) Furthermore, Fraction I was 3- to 15-fold more active than Fraction II in stimulating cholesteryl ester formation in mouse peritoneal macrophages. The concentration of Fraction I, but not Fraction II, was diminished in plasma by prolonged fasting, and Fraction I transported more intestinal-absorbed retinol than Fraction II. In addition, the plasma clearance of Fraction I injected into cholesterol-fed dogs was distinctly different from the clearance of Fraction II, and the in vivo dieaway of Fraction I resembled that of chylomicrons and chylomicron remnants. These findings suggest that ßbeta;-VLDL in dogs are composed of cholesteryl ester-rich chylomicron remnants (Fraction I) and cholesteryl ester-rich lipoproteins, probably of liver origin (Fraction II). Finally, in studies of two patients with Type III hyperlipoproteinemia, we also identified the existence of two fractions in the ßbeta;-VLDL with characteristics similar to Fractions I and II of cholesterol-fed dogs.—Fainaru, M., R. W. Mahley, R. L. Hamilton, and T. L. Innerarity. Structural and metabolic heterogeneity of ßbeta;-very low density lipoproteins from cholesterol-fed dogs and from humans with Type III hyperlipoproteinemia.

Supplementary key words dysbetalipoproteinemia • mouse peritoneal macrophages • cholesteryl esterification

Submitted on December 2, 1981
Revised on March 4, 1982

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Campos, D. Perlov, C. Khoo, and F. M. Sacks Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia J. Lipid Res., August 1, 2001; 42(8): 1239 - 1249. [Abstract] [Full Text] [PDF]

				S. Marathe, Y. Choi, A. R. Leventhal, and I. Tabas Sphingomyelinase Converts Lipoproteins From Apolipoprotein E Knockout Mice Into Potent Inducers of Macrophage Foam Cell Formation Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2607 - 2613. [Abstract] [Full Text] [PDF]

				K. C-W. Yu, Y. Jiang, W. Chen, and A. D. Cooper Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E J. Lipid Res., November 1, 2000; 41(11): 1715 - 1727. [Abstract] [Full Text]

				R. W. Mahley, Y. Huang, and S. C. Rall , Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes J. Lipid Res., November 1, 1999; 40(11): 1933 - 1949. [Abstract] [Full Text]

				G. Asset, E. Baugé, R. L. Wolff, J. C. Fruchart, and J. Dallongeville Pinus pinaster Oil Affects Lipoprotein Metabolism in Apolipoprotein E-Deficient Mice J. Nutr., November 1, 1999; 129(11): 1972 - 1978. [Abstract] [Full Text]

				S. C. Whitman, S. L. Hazen, D. B. Miller, R. A. Hegele, J. W. Heinecke, and M. W. Huff Modification of Type III VLDL, Their Remnants, and VLDL From ApoE-Knockout Mice by p-Hydroxyphenylacetaldehyde, a Product of Myeloperoxidase Activity, Causes Marked Cholesteryl Ester Accumulation in Macrophages Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1238 - 1249. [Abstract] [Full Text] [PDF]

				X. Qian, M. E. Balestra, S. Yamanaka, J. Boren, I. Lee, and T. L. Innerarity Low Expression of the Apolipoprotein B mRNA–Editing Transgene in Mice Reduces LDL Levels but Does Not Cause Liver Dysplasia or Tumors Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 1013 - 1020. [Abstract] [Full Text] [PDF]

				S. C. Whitman, D. B. Miller, B. M. Wolfe, R. A. Hegele, and M. W. Huff Uptake of Type III Hypertriglyceridemic VLDL by Macrophages Is Enhanced by Oxidation, Especially After Remnant Formation Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1707 - 1715. [Abstract] [Full Text]

				M. M. Hussain, T. L. Innerarity, W. J. Brecht, and R. W. Mahley Chylomicron Metabolism in Normal, Cholesterol-fed, and Watanabe Heritable Hyperlipidemic Rabbits J. Biol. Chem., April 14, 1995; 270(15): 8578 - 8587. [Abstract] [Full Text] [PDF]

				M Yokode, R. Hammer, S Ishibashi, M. Brown, and J. Goldstein Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors Science, November 30, 1990; 250(4985): 1273 - 1275. [Abstract] [PDF]